1. Home
  2. FWBI

FWBI

First Wave BioPharma Inc.

Logo First Wave BioPharma Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

First Wave BioPharma Inc is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. It is advancing a therapeutic development pipeline populated with multiple clinical-stage programs built around its two proprietary technologies-niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.

Founded: N/A Country:
United States
United States
Employees: N/A City: BOCA RATON
Market Cap: 6.9M IPO Year: 2016
Target Price: $36.00 AVG Volume (30 days): 122.6K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -47.88 EPS Growth: N/A
52 Week Low/High: $2.75 - $73.00 Next Earning Date: 04-19-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: